News Center
The most reliable way to compare top fertility clinics for IVF in the United States is to look at how each one handles cycle cancellation. Headline live birth rates reward clinics that quietly decline difficult patients, so the real question is whether a clinic filters you out or builds a plan around you. The three questions in this article will show you which kind of clinic is sitting across the desk from you.
Every year, the Society for Assisted Reproductive Technology (SART) and the U.S. Centers for Disease Control and Prevention (CDC) publish clinic-by-clinic outcome reports. Most patients open those reports, find the live birth rate column, and assume the highest number belongs to the strongest clinic. That assumption breaks down once you understand one line buried deeper in the same report: the percentage of started cycles that were cancelled before embryo transfer.
Here is the mechanics of it. A live birth rate can be calculated per embryo transfer or per cycle started. A clinic that only counts cycles reaching transfer will always post a higher number than a clinic that counts every patient who walked in and injected stimulation medication, because cancelled cycles vanish from the numerator while the clinic keeps the freedom to select which patients ever reach that stage. SART's own reporting framework distinguishes these denominators, and the CDC's ART patient reports note how many initiated cycles never produced a transfer. Both organizations publish the raw material for a fairer comparison. Few patients read that far.
A simplified illustration shows how large the gap can become. Imagine two hypothetical clinics, each treating 100 women aged 40 with their own eggs. Clinic A accepts everyone and cancels 40 cycles for poor follicular response, then achieves 15 births from the 60 transfers performed. Clinic B applies a strict screening cutoff, cancels 55 cycles before stimulation even begins, and achieves 14 births from 45 transfers. Clinic B's per-transfer live birth rate looks dramatically higher, roughly 31% against 25%, even though Clinic A delivered more babies to more patients. The published tables would flatter Clinic B. Nothing in the headline number is false; the selection upstream did the work.
This is not an accusation of dishonesty in the legal sense. SART-member clinics report under defined audit standards, and the numbers are accurate as reported. The distortion lives in what the metric measures, not in whether the metric is reported truthfully. A per-transfer rate answers a narrow question: among patients who made it to transfer, how often did it work? Patients searching for the best hospital for IVF usually want the answer to a different question: if someone like me walks in and commits to treatment, what is my realistic chance of taking a baby home? Those two questions produce different rankings, and the divergence widens with every year of age and every point of lower ovarian reserve.
Condemning cancellation outright would be its own mistake. Fertility physicians cancel cycles for reasons that protect patients, and a clinic that never cancels anything should worry you as much as one that cancels reflexively.
The distinction that matters is between clinical cancellation and statistical cancellation. Clinical cancellation happens when continuing carries genuine risk or futility, and the physician explains the reasoning, documents it, and proposes a modified plan. Statistical cancellation happens when a patient with low odds is declined not because treatment would harm her, but because her outcome would sit inside the clinic's published denominator and drag the numbers down. The two can look identical from the outside. They feel very different from inside the exam room, and the difference surfaces in how the clinic talks about your specific situation.
Patients with diminished ovarian reserve, an elevated FSH, a low antral follicle count, or an age above 40 are the groups most affected by this boundary. A 42-year-old with an AMH of 0.4 may be told at one center that she is not a candidate for treatment with her own eggs, and at another that she is a candidate with modified expectations and a specific protocol designed for exactly her profile. Both statements can be honest. Only one of them leaves the decision with her.
You do not need access to internal data to probe this. The first consultation is a two-way assessment, and the way a physician answers three specific questions tells you more than any ranking list. Ask them in order, listen to the structure of the answers, and take notes.
This question forces the per-cycle-started denominator into the conversation. A clinic confident in its approach to difficult patients will give you a figure or a close approximation without defensiveness, because a modest transfer rate paired with honest counseling is exactly what a program treating the full spectrum of patients looks like. Watch for three response patterns.
One pattern is a direct number plus context, something along the lines of acknowledging that at your age roughly half of started cycles reach transfer, with an explanation of which factors push a cycle toward cancellation and what the clinic does to reduce that. That answer signals a program that tracks its own behavior and accepts the published consequences of treating hard cases.
A second pattern is a pivot to the per-transfer rate, delivered smoothly, with reassurance about excellent outcomes among those who proceed. The number may be true. The framing quietly removes people like you from the picture before you have even been evaluated. Treat it as a flag worth investigating, not a verdict on the clinic.
A third pattern is refusal to engage at all, on the grounds that statistics do not apply to individuals. There is a legitimate version of this point, since any single patient's outcome is binary, but a clinic using it to dodge a straightforward operational question is telling you how future difficult conversations will go.
Every program operates with some response threshold below which continuation stops making sense. The revealing part is how rigid the threshold is and who controls it. Ask what happens specifically if you produce two follicles on day eight of stimulation. Then listen for the clinical strategy hiding inside the answer.
A rigid institutional cutoff, quoted as a fixed follicle number or estradiol level with no room for judgment, suggests a program optimized for throughput and tidy statistics. Rigid cutoffs are efficient and defensible in aggregate, and some patients prefer their clarity. The tradeoff is that borderline patients get sorted out by policy rather than by individualized reasoning.
An individualized answer describes the physician weighing your age, prior response, antral follicle count, and personal goals, then presenting options: proceed to retrieval and accept a small yield, convert to a modified natural or mini-stimulation approach, adjust the protocol and try again, or stop. The key phrase to listen for is a concrete alternative plan. A clinic that has treated many low-reserve patients has a repertoire ready. A clinic that has not will describe the cancellation and leave the next step vague.
There is also a diagnostic version of this question worth asking: does the physician explain that a cancelled cycle still produces information? A poor first response maps your ovarian behavior and drives protocol selection for attempt two. Programs experienced with difficult patients treat a low-yield cycle as data. Programs oriented toward select patients treat it as a closed door.
The first two questions probe philosophy. This one probes infrastructure. A program that genuinely serves patients with reduced ovarian reserve has built operational machinery for the cancelled-cycle scenario, and you can verify its existence in a single answer.
Listen for specifics. Does the clinic offer modified natural cycle IVF or mini-stimulation as a standing option, which uses minimal or no gonadotropin medication and dramatically lowers the cost of a low-yield attempt? Some programs known for this approach, such as New Hope Fertility Center in Manhattan and CNY Fertility in New York, have built substantial parts of their practice around milder protocols precisely because they keep treatment accessible to patients whom aggressive protocols would price out or screen out. Does the clinic offer a second stimulation in the same menstrual window for selected patients? Does it have a defined re-protocol review, where the physician revisits medication choice, trigger timing, and supplement strategy before the next attempt? Is there a financial structure, such as multi-cycle pricing, that acknowledges more than one attempt may be needed?
Compare that against the answer where cancellation leads back to the same standard protocol at the same price, with the implicit message that the next attempt is a rerun of the last one. Repetition without modification is the most expensive form of hope in fertility care, and it is the default outcome at programs whose patient mix never required them to build alternatives.
Clinic type predicts cancellation behavior better than any ranking does, and the published reports from SART and the CDC let you check each program's actual cancellation percentages before you commit to a consultation. Three broad models dominate the American landscape.
High-volume national networks. Groups such as Shady Grove Fertility, with dozens of locations across multiple states, and HRC Fertility, with several Southern California centers, run standardized protocols at scale. Standardization brings consistency, established lab quality, and often financial programs including shared-risk or refund plans that partially insure you against a cancelled or unsuccessful cycle. The tradeoff is that protocols are built around the statistical middle of the patient population. Patients well outside that middle sometimes find the pathway less flexible than they hoped, though large networks also contain physicians with individualized practices, so the specific doctor matters as much as the brand.
Mild-stimulation and accessibility-focused programs. CNY Fertility has built a national reputation on lower-cost cycles and mini-stimulation protocols, attracting patients with low ovarian reserve and patients paying out of pocket. New Hope Fertility Center in Manhattan has long emphasized natural and minimal stimulation cycles and serves a large international patient base. The clinical logic of these programs aligns with the cancellation discussion above: when a cycle yields one or two eggs, the financial and physical cost of that attempt is low enough that trying remains rational. Published per-transfer success rates at such programs may read lower than those of selective high-volume centers, partly because their patient mix includes precisely the cases other programs decline. Whether that trade suits you depends on your priorities and finances, and you should verify current pricing and protocols directly with each program.
Academic-affiliated and boutique centers. University-connected programs and smaller boutique practices often sit between these models, with physician-driven protocol flexibility and case-by-case decision making. The variability within this category is high, which makes the three questions above more important here than anywhere else, since reputation and structure vary widely from one center to the next.
None of these models is universally correct. A 29-year-old with tubal factor infertility and normal reserve will do well almost anywhere and should weigh convenience, cost, and insurance coverage. A 43-year-old with an AMH near the detection floor is choosing between programs on a completely different axis, and cancellation policy sits at the center of that choice.
The SART clinic reports and the CDC's annual ART reports both disclose, for each clinic, the number of cycles started, the number cancelled, and outcomes broken down by age group and by whether patients used their own eggs. Reading them takes twenty minutes and changes what you see.
One caution applies to all of this. Published rates describe populations from a specific reporting period at a specific program. Your individual outcome depends on factors no table captures, and every legitimate physician will say so. Use the data to eliminate programs whose behavior pattern does not fit you, rather than to crown a single winner.
Preparation converts the three questions from conversation starters into negotiation tools.
The most expensive mistake is ranking clinics purely on headline success rates and then choosing the top number without checking who was counted. The second is assuming that a clinic declining treatment is delivering a medical verdict on your fertility rather than a statement about its own protocol boundaries, which is why a second opinion from a program with a different patient philosophy carries real informational value, not just reassurance. The third is treating a cancelled cycle as a failure that ends the process, when in well-run programs it functions as a diagnostic step that shapes every attempt after it. The fourth is ignoring the financial architecture until the second cycle, when multi-cycle and refund-style programs should have been part of the initial comparison.
A quieter mistake is age-based fatalism absorbed from clinic behavior. Declining ovarian reserve is real and progressive, and no protocol reverses it. Within that constraint, however, the spread between a program that offers a tailored mild-stimulation pathway and one that applies a rigid cutoff is frequently the difference between several more attempts and none. Patients who hear one no often assume the no was universal. It rarely is.
Shift the comparison from who publishes the best number to who publishes the fullest picture. Pull the SART and CDC reports for your shortlist, read the cancellation percentages next to the success rates, and let that pair tell you what kind of program each clinic actually is. Then take the three questions to your first consultation and listen to whether the answers describe a system built to move you toward transfer or a system built to keep its statistics clean. Clinics of both kinds operate openly across the United States, from high-volume networks like Shady Grove Fertility and HRC Fertility to mild-stimulation programs like CNY Fertility and New Hope Fertility Center, and each serves a legitimate patient population. Your job is to identify which population you belong to and choose accordingly, with the understanding that all published figures are historical population statistics and current details should be confirmed directly with each program.
